Washington, DC 20006-5349
HELPLINE
In an analysis published last week, the Centers for Disease Control and Prevention (CDC) reported a significant increase in mesothelioma deaths among women during the…
The diagnosis Julie went to the 2006 International Symposium on Malignant Mesothelioma with her neighbor who is a medical doctor. She needed someone with her…
This week, the paper “Medical and surgical care of mesothelioma patients and their relatives carrying germline BAP1 mutations,” by Drs. Michele Carbone, Harvey Pass, and…
The next few weeks are packed with support and conversation groups, and community events. To make it easier for everyone to plan ahead, take a…
Over the last 7 days, we have shared important facts about asbestos with our community. While mesothelioma patients and their families are painfully aware of the dangers of this ubiquitous material, please make sure to share this information with your communities so they, too, become aware. Many Americans mistakenly think…
Data from a study comparing the efficacy of anetumab ravtansine, a monoclonal antibody conjugate, against vinorelbine showed no improvement in progression-free survival. The results of…
Join us to learn more about financial assistance programs for patients and caregivers traveling to obtain treatment or enroll in a clinical trial; and funding…
The Meso Foundation’s Executive Director Julie Powers came up with 10 questions to ask during her interview with our Patient Services Director Shannon Sinclair, RN,…
In this MesoTV episode, we are joined by Dr. Marjorie Zauderer, a medical oncologist at Memorial Sloan Kettering Cancer Center. Dr. Zauderer talks about the…
Two young mesothelioma patients talk about the moment that led up to their diagnosis, how they learned about the Meso Foundation, and how getting a…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
